WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹105 Cr | ₹68 Cr | ₹109 Cr | ₹61 Cr | ₹9.13 Cr |
What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹105 Cr |
| Mar2025 | ₹68 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹9.13 Cr |
How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹105 Cr | 53.89 | |
| Mar2025 | ₹68 Cr | -37.42 | |
| Mar2024 | ₹109 Cr | 78.73 | |
| Mar2023 | ₹61 Cr | 567.74 | |
| Mar2022 | ₹9.13 Cr | - | |
Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,050.2 Cr | 9.6% | -2.5% | -2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 9.6% |
-2.5% |
-2% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses